# GSK plans phase 3 after mRNA flu vaccine beats standard shots

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-01 20:29 UTC · Category: Business · Sources: 12 · Current Velocity: 10.39

## Intelligence Brief
"GSK plans phase 3 after mRNA flu vaccine beats standard shots" developed substantial multi-source reporting across the Business sector, tracked across 12 distinct newsrooms by Newsylist.


Key reporting was led by BioPharm International, 2 Minute Medicine, finance.biggo.com and Seeking Alpha. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for GSK plans phase 3 after mRNA flu vaccine beats standard shots?
Coverage spiked when 12 independent newsrooms published 12 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| BioPharm International | GSK Advances mRNA Flu Vaccine Candidate to Phase 3 After Positive Phase 2 Data | 2026-09-01 09:43 | [Source Link](https://news.google.com/rss/articles/CBMiwgFBVV95cUxOaWxwNXQtSnBvblBQV1FFZzVXS3FjSF9jSS1USEVLOGY2ZmxzNlhDcGljckJKZFNYQi1VQWFlb3FhMHJfWHJla3NTOXFkSy1VMGlIQUxvVjh6S0RmMF8zVVhUa200R0lUNGtmNUlJYVQ4cWtUODlhQkpqcDR5SU1rSHBtS1g4SU1TZnd0cHNQS3Nkb0tsUUZpMlZSQmY4aFo3d2dnUHlWM2g2LWVtamRoZWhjaEliVkZwOEVsX1QwMmpJZw?oc=5) |
| 2 Minute Medicine | mFlusiva becomes the first mRNA influenza vaccine approved by the FDA | 2026-09-01 09:43 | [Source Link](https://news.google.com/rss/articles/CBMipAFBVV95cUxOd1ltYmZhcUxPb005TEEtaVdrUTM5ckxBanN2dGdGWVVIWkMwbS1nUzVJbUZsUUtjTTFrbXpiU2ZKQmhCSUJ5UEplaGFtaHVYRzVMN2JQX01ZZ254VjlEaVE4aUJoVlpWUUQ1TjRQUklBbmhlUGhWNGZPXzh1OEV2N0g5VHVuWXVBWmh4aE5UNU1oUDBjY1Y2VVJLd3EwRkc0dnV3RQ?oc=5) |
| finance.biggo.com | GSK Advances mRNA Flu Shot to Phase 3 After Beating Standard Vaccines in Mid-Stage Trial | 2026-09-01 09:43 | [Source Link](https://news.google.com/rss/articles/CBMidkFVX3lxTE5jVXZxV21TLTBwQ2k2dS1fVUlxY2RiRV96U0hiU3RhTVo0Q3YtWS1Md0NocjlTRDIxRVJ0aEhsVGlzWFRvalJxSDlzNkYtelJoUk1CRXpHZGhVT3B4RWtfX2dseGNKUllEVTNBY3I5RFBBd21wOWc?oc=5) |
| Seeking Alpha | GSK: Still One Of My Top Healthcare Picks | 2026-09-01 09:43 | [Source Link](https://news.google.com/rss/articles/CBMiiAFBVV95cUxPM0dXNllEQmQxRGNNclE0RDBxakpiX3hFcGVseHZHTVNmOW8ybkM2VmVRaTZtZmxoU2N4bGlKS0R2ZTZ0eDRIRVBYNmgxb08zZUtMeFRRQVludWR4bmQ0Uk9zNTExMzgxM2dQbWNVUmYwNVAwN19IWVZ0ZHNycXdwNzl3YkFDaWpr?oc=5) |
| Westlaw Today | GSK to advance mRNA flu vaccine to late-stage trial - Business Information & News | 2026-09-01 09:43 | [Source Link](https://news.google.com/rss/articles/CBMi3AFBVV95cUxOY3ZrWGdsSmZTY2ExM2hhSV8tR2pBX0lKeW5VeEttNnEyQk1hcmZ6QXpZWHRjWDlIVGlrV3FmMDdOUjZMejMzQWhkMmtFWTFrb1pVaHl1em9mdTVjUDNwbEJYaEcybG9BaHR1MXpYYllwejZxSHBaSVZqdlhtRkNaOEhldWNKUlV6SVU0SlMzblF5ZDdxckpKeXBMRUVyQnphb3J4ck1TSWx4NW51eFEyZ1pnb2ItLTFoYWdWQTM3ZF9yZmJyU2lDdWJqQTVsRDlDSVE3cjhkRm1Scm9Z?oc=5) |
| Endpoints News | GSK to launch Phase 3 test of mRNA flu vaccine with newer formulation | 2026-09-01 09:43 | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxOLVdJVF9ONW9POVBKaXMzN3VRczlJWl90NG1HRWJzWk5IVmYzd0M1VW1MSWZyS2NQUzM1VHYzT25vendya2FMQTk2bnpZX0dfbkJubTNkLTlCMFpfaWJVY002b3pSSTVQWEpta1FGWURKRVRWZEFYSjRSNUU2OHBOUFI1ZkFKQXljUERSLTUzaWphZDV4YWVMNQ?oc=5) |
| Contagion Live | GSK's mRNA Influenza Vaccine Moves to Phase 3 Trial | 2026-09-01 09:43 | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxQQ2hTU2JmYVo3N2lKdzQ1Z3MxVVYzcGxkczVPb2FKMnFINmloM3NWNEs0NGJnVlJnWW5YZnZ2ZWJEdXd4ZS0zRHNQaGRuQlZ2YUN1aXBhd2lkRkUxQldySnFKUXZjMTVrQzNzTUVTQlQxV3RxbHV4UlFBQ0lrbDRtZmNDcTNQeEljOE0yZHpISQ?oc=5) |
| pharmaphorum | GSK pushes 'next-generation' mRNA flu shot into phase 3 | 2026-09-01 09:43 | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxQV1RVU0N6MWZhVDFKMENNUk44TnAzSmNMTHhpU1ctaEdOcFUtb0lDZnNiaGU3R2lTQmVSR2V3SkY2TVJQSTk2WFRMNTB4NXhMTEMtRlNpcUNGWVRuTTJNVVpmcF9NM3JSTnlyMTQzVGQzTlQzOWgyVl9xQ2xfQ2VKRkVzNGQ?oc=5) |
| FirstWord Pharma | GSK takes dual-target mRNA flu shot to Phase III | 2026-09-01 09:43 | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTFA3WmstQlE2cHFRNHkxc0E5S0hfS1hyRTlLTEw5Nmc1NVJFLXpXUGc4dk9VeEhqWWI1ek9fUURJQnNoRlFVRXlCcWZGZWZwMTI2QllJ?oc=5) |
| 24/7 Wall St. | Moderna Rises 6% Despite GSK Moving Rival mRNA Flu Vaccine to Phase III | 2026-09-01 09:43 | [Source Link](https://news.google.com/rss/articles/CBMitAFBVV95cUxOU1U4OV9SQ3RtLWktMVhHWnQyWmdFTXM0SC1paGQ5R05hX0Z3YV85Q05OWTBXYVBnVllnSzVRdy10eXltR1VUOGs5TEFzTnlLT3NXSWRKNnJjN3VuSWtRT2ZEM0tIR2s4dXk2Tk1qYlE2WEhmZ1lVa2VlWjNqeUJ1akc5RS1UUGQzckdBREE2NkxUc3Z5ZndkckhLNlJBdVphUHVsRnEzdVdiSHZPWmpHNldPWGc?oc=5) |
| Arab News | New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine | 2026-09-01 09:43 | [Source Link](https://news.google.com/rss/articles/CBMivgFBVV95cUxONkVKSF9aa0g3VWtlUmY5NFhXemxZQmVZQXY4ZWtiU1lPdW1fNEhlZ1d6WjNxWlYxQnN3a0xlNndLLUY3VU5wVE9WcVJuQkd3OENvY25WVlpwMk1IUDlhNGUyUE1vMFgxOVdQZDNqbE15UTM3RU9ZczA0NDNoXy1Pd2tvUC1xWmFxRGp2a3hDSTdMRzNOWEZIaTI4QnRIcjJIbVZFWnNPZDZPN1dvcVRERXhOd20xZEhGOGtieTln?oc=5) |
| Connecticut Public | New flu shot could give older adults better protection, CT health official says | 2026-09-01 09:43 | [Source Link](https://news.google.com/rss/articles/CBMiuwFBVV95cUxQV3p6WVE2aFVNNmFFS1VmNUZZRENJWnhMRFpubUFfbFZRSzNMMHFkQ01nWW1rakRhZWR2b2M4enljWjdheEFEU0hRcTU3dWhBNEs2Q1g0cWRpcG1YTURYRS1HVThLN1Z2YmQ2a0JteER3cG4wSzJzT3JCdktSbHB5MWg5emp3bUdrX0dZNzFfSV9GV0xVdWpHc3RCRDFnRGZ0Slh6YmhHdHRPcjZRVUpIUGdacUtVWjJsR1dj?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-01/gsk-plans-phase-3-after-mrna-flu-vaccine-beats-standard-shots*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*